One Punch Isn’t Enough to Overcome a Common Cancer Mutation

BBS student, Eileen Ablondi, is featured in a Harvard Medicine News article.

Cancer cells are often a mess of mutations. About 20 to 25 percent of cancers involve mutations in a complex of molecules called SWI/SNF. Yet drugs designed to block SWI/SNF activity haven’t always worked as expected.

Researchers at Harvard Medical School have now figured out why.

Read more here: https://hms.harvard.edu/news/one-punch-isnt-enough-overcome-common-cancer-mutation